| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/03/1997 | EP0792330A1 A chitosan polymer having a specific degree of acetylation |
| 09/03/1997 | EP0792279A1 Antibiotic cryptdin peptides and methods of their use |
| 09/03/1997 | EP0792275A1 Improved antiviral prodrugs |
| 09/03/1997 | EP0792165A1 Immunogenic compositions |
| 09/03/1997 | EP0792164A1 Composition, device, and method for enhanced electrotransport agent delivery |
| 09/03/1997 | EP0792161A1 Hydrogel microencapsulated vaccines |
| 09/03/1997 | EP0792158A1 Use of angiotensin ii fragments and analogs thereof in tissue repair |
| 09/03/1997 | EP0792154A1 Composition of cisplatin in combination with 2,2'-dithio-bis(ethanesulfonate) (dimesna) |
| 09/03/1997 | EP0792149A2 Oral compositions containing ondansetron |
| 09/03/1997 | EP0792147A1 Pharmaceutical composition comprising non-steroidal anti-inflammatory drugs |
| 09/03/1997 | EP0792145A1 Transdermal resorption of active substances from supercooled masses |
| 09/03/1997 | EP0792144A1 Cleaning tissues treated with water-in-lipid emulsion |
| 09/03/1997 | EP0792143A1 Methods and apparatus for making liposomes containing hydrophobic drugs |
| 09/03/1997 | EP0792142A1 Bilayer stabilizing components and their use in forming programmable fusogenic liposomes |
| 09/03/1997 | EP0792137A1 Antifungal treatment of nails |
| 09/03/1997 | EP0792124A1 Medical devices composed of low ceiling temperature polymers |
| 09/03/1997 | EP0755672B1 Silicon composition containing a water-sensitive agent |
| 09/03/1997 | EP0593552B1 Process for preparing drug substances in beadlet form |
| 09/03/1997 | EP0572627B1 Solvent system to be enclosed in capsules |
| 09/03/1997 | EP0542923B1 Liposomes that provide thymic dependent help to weak vaccine antigens |
| 09/03/1997 | EP0391905B1 Use of disaccharide polysulfate-aluminium compound in the manufacture of a medicament for treating HEMORRHOIDs and for wound healing |
| 09/03/1997 | CN1158619A Delivery of nucleic acids |
| 09/03/1997 | CN1158572A Peroral immunogen compsn. and process for producing the same |
| 09/03/1997 | CN1158566A Pharmaceutical compsn. for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for treatment thereof |
| 09/03/1997 | CN1158565A Aqueous foamable compsn. |
| 09/03/1997 | CN1158257A Universal injury liquid and its prepn. method |
| 09/03/1997 | CN1158256A Pear skin growth powder |
| 09/03/1997 | CN1158255A Anti-cancer injection and its prepn. method |
| 09/03/1997 | CN1158248A Method for prepn. of compound preparation by using Chinese medicine folk prescription preparation |
| 09/02/1997 | USRE35601 Delivery device providing beneficial agent stability |
| 09/02/1997 | US5663387 Liposomes containing polymerized lipids for non-covalent immobilization of proteins and enzymes |
| 09/02/1997 | US5663205 Pharmaceutical composition for use in glaucoma treatment |
| 09/02/1997 | US5663198 Drug formulations comprising coated, very sparingly water-soluble drugs for inhalational pharmaceutical forms, and process for their preparation |
| 09/02/1997 | US5663170 Diabetes |
| 09/02/1997 | US5663156 Mixture of higher primary aliphatic alcohols, its obtention from sugar cane wax and its pharmaceutical uses |
| 09/02/1997 | US5663145 Products for administering an initial high dose of Cetrorelix and producing a combination package for use when treating diseases |
| 09/02/1997 | US5662957 Blending surfactants with wall forming material and oil,and then with aqueous diluent; food for molluscs |
| 09/02/1997 | US5662938 Polymers of glycolic and/or lactic acid, drug delivery, sustained release |
| 09/02/1997 | US5662936 Sugar-coated pharmaceutical dosage unit |
| 09/02/1997 | US5662935 Process for preparing controlled release pharmaceutical forms and the forms thus obtained |
| 09/02/1997 | US5662933 Sustained release drugs with gels |
| 09/02/1997 | US5662932 Particles with a core of lipid surrounded by phospholipid envelope; drug delivery |
| 09/02/1997 | US5662931 Process for preparing liposome composition |
| 09/02/1997 | US5662930 Reduction of liposome-induced adverse physiological reactions |
| 09/02/1997 | US5662929 Bactericides using liposomes |
| 09/02/1997 | US5662928 Method for the prevention or removal of crystalline scopolamine in a non-aqueous matrix of a transdermal system |
| 09/02/1997 | US5662926 Solvent free |
| 09/02/1997 | US5662925 For administering an active agent to the skin or mucosa of an individual |
| 09/02/1997 | US5662923 Self-adhesive |
| 09/02/1997 | US5662920 Nicotine lozenge and therapeutic method for smoking cessation |
| 09/02/1997 | US5662919 Hydrolytic stability of drugs using sulfated polyvinyl alcohol copolymers |
| 09/02/1997 | US5662918 Bone disorders, storage stable |
| 09/02/1997 | US5662917 Release-controlled implantable somatotropin composition |
| 09/02/1997 | US5662904 Anti-scarring compositions comprising growth factor neutralizing antibodies |
| 09/02/1997 | US5662890 Self-tanning cosmetic compositions and methods of using the same |
| 09/02/1997 | US5662883 Microprecipitation of micro-nanoparticulate pharmaceutical agents |
| 09/02/1997 | US5662849 Method and apparatus for forming compression dosage units within the product package |
| 09/02/1997 | US5662758 Composite material releasably sealable to a target surface when pressed thereagainst and method of making |
| 09/02/1997 | US5662732 Polish composition |
| 09/02/1997 | US5662626 To be attached to the skin |
| 08/29/1997 | CA2198690A1 Prophylactic/therapeutic composition for secondary cataract |
| 08/28/1997 | WO1997030778A1 Novel artificial pancreas |
| 08/28/1997 | WO1997030730A1 Fine grain carriers and medicinal composition prepared with the use of the same |
| 08/28/1997 | WO1997030726A1 Iscom or iscom-matrix comprising hydrophobic receptor molecules for antigenic substances |
| 08/28/1997 | WO1997030725A1 Cochleat delivery vehicles |
| 08/28/1997 | WO1997030721A1 Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
| 08/28/1997 | WO1997030720A1 Method of producing an enterosorbent |
| 08/28/1997 | WO1997030714A2 Topical pharmaceutical composition containing heparin |
| 08/28/1997 | WO1997030711A1 External preparation for curing lesioned tissues |
| 08/28/1997 | WO1997030700A2 Composite material for medical, cosmetic and sports purposes and methods for the preparation thereof |
| 08/28/1997 | WO1997030699A2 Dosage form of ibuprofen |
| 08/28/1997 | WO1997030698A1 Effervescent ibuprofen preparation and process for the production thereof |
| 08/28/1997 | WO1997030697A1 Method of treating alopecia |
| 08/28/1997 | WO1997030696A1 Liposome and liposome dispersion |
| 08/28/1997 | WO1997030695A1 Drug delivery compositions suitable for intravenous injection |
| 08/28/1997 | WO1997030693A1 Suppository composition of the drug which undergo the hepatic first-pass effect |
| 08/28/1997 | WO1997030692A1 Cosmetic, dermopharmaceutical or veterinary compositions for disinfecting human or animal skin |
| 08/28/1997 | WO1997030686A1 Cosmetic deodorant products containing encapsulated bicarbonate and fragrance ingredients |
| 08/28/1997 | WO1997030656A1 Male contraceptive implant |
| 08/28/1997 | WO1997030601A1 Liquid oral compositions comprising a calcium compound and an acidulant |
| 08/28/1997 | DE19606804A1 Planned release of active substance |
| 08/28/1997 | CA2247270A1 Liposome and liposome dispersion |
| 08/28/1997 | CA2247258A1 Method of treating alopecia |
| 08/28/1997 | CA2247206A1 External preparation for curing lesioned tissues |
| 08/28/1997 | CA2245522A1 Particulate carriers and pharmaceutical compositions containing the same |
| 08/28/1997 | CA2218623A1 Novel artificial pancreas |
| 08/27/1997 | EP0791354A1 Method of making controlled release devices |
| 08/27/1997 | EP0791061A1 Animals with targeted gene disruption |
| 08/27/1997 | EP0791037A2 Process for stabilizing gelatin products |
| 08/27/1997 | EP0790823A1 Drug releasing surgical implant or dressing material |
| 08/27/1997 | EP0790822A1 Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure |
| 08/27/1997 | EP0790821A1 Pharmaceutical nanosuspensions for medicament administration as systems with increased saturation solubility and speed of dissolution |
| 08/27/1997 | EP0767660A4 Methods and formulations for modulating the human sexual response |
| 08/27/1997 | EP0681476B1 Unit dose form of bismuth subsalicylate |
| 08/27/1997 | EP0641216B1 PHARMACEUTICAL COMPOSITIONS CONTAINING IL-6 stabilized with a non-reducing sugar |
| 08/27/1997 | EP0607231B1 Use of an emulsion to prepare an intravenously administered medicament for treating skin diseases |
| 08/27/1997 | EP0575454B1 Use of cucurbitine for the preparation of a cosmetic or pharmaceutical, particularly dermatological, antiallergic composition and method involving application thereof |
| 08/27/1997 | EP0560845B1 Cell proliferation matrix and use thereof |
| 08/27/1997 | EP0559827B1 High amylose starch substituted gelatin capsules |
| 08/27/1997 | EP0547203B1 In vivo delivery of active factors by co-cultured cell implants |